Natco Pharma net up 32%
Total income from operations up by 14% at Rs 203 cr
Last Updated at February 14, 2014 23:24 IST
Hyderabad-based Natco Pharma Limited reported a 32.27 per cent jump in net profit at Rs 29.88 crore for the quarter ended December, 2013 on the back of increased revenues from the formulations business.
The company's net profit during the corresponding previous quarter was Rs 22.59 crore. Total income from operations grew 14.49 per cent at Rs 203.36 crore as compared with Rs 177.61 crore in the year ago period.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
First Published: Fri, February 14 2014. 20:39 IST